Product details

Regulatory note: Investigational combination; not approved as a finished drug at the time of writing. Components carry individual CAS numbers — confirm each component's API identity by batch COA / label before use. Sold for Research Use Only under the receiving laboratory's institutional and jurisdictional regulations — not a finished dosage form and not labelled for human administration. Buyers are responsible for institutional biosafety review and import-eligibility verification.

FAQ

Does Peptuno supply CagriSema as a pre-mixed blend?

No. Peptuno supplies Cagrilintide and Semaglutide as separate characterized lots, each with its own analytical packet, rather than a pre-mixed vial. This lets a lab confirm the identity and purity of each component independently before preparing the combination in-protocol — the methodologically cleaner approach, because a pre-mixed product obscures the per-component analytical data a citable methods section needs.

Why does CagriSema not carry a single CAS?

CagriSema is a combination of two distinct molecules, each with its own CAS Registry Number, rather than a single chemical entity, so there is no single registered identifier for the pairing. Identity is established at the component level on each lot COA (ESI-MS against the theoretical mass for each supplied form); buyers should confirm the API of each component by COA or label rather than relying on the combination name.

What is the analytical basis for treating the two components as a reference pairing?

Each component is independently characterized — RP-HPLC purity, ESI-MS identity, LC-MS/MS sequence verification on request, counter-ion content, and water content by Karl Fischer — so the pairing is defined by two citable per-lot data packets rather than a single blended COA. A lab reconstitutes and combines the two at its chosen ratio in-protocol, with each component's identity already confirmed against its own standard.

Certificate of Analysis (COA)